Third largest pharmaceuticals industry in the world by volume with a current evaluation of US$41bn.

60,000

generic brands in 60 therapeutic categories.

No.1

provider of generic medicines globally.

50%

of global supply for vaccines comes from India.

3,000

pharma companies in the Indian industry.

+500

different Active Pharmaceutical Ingredients (APIs) manufactured in India.

60,000

generic brands across 60 therapeutic categories are sourced from India.

US$18.2bn

domestic pharmaceuticals market turnover reported in 2018.

Largest

US-FDA, WHO-GMP, EDQM, MHRA compliant pharma base outside the US.

US$19.1bn

value of pharmaceutical exports reported from India in 2018-19.

100%

FDI is allowed under the automatic route for greenfield pharma projects.

US$100bn

expected valuation of the Indian pharmaceutical sector by 2025.

US$25bn

expected valuation of the medical device market by 2025.

Indian Drug Manufacturers’ Association

admin@idmaindia.com

+91-22-2494 4624 / 2497 4308

Visit Website

IDMA members’ Indian market share is about 75% in formulations and about 85% in APIs.

Pharmaceutical Export Promotion Council

jitendra.trivedi@gov.in

+91-11-23324930

Visit Website

Pharmexcil is the authorized agency of the government of India for promotion of pharmaceutical exports.

Federation of Pharma Entrepreneurs

fope2013@gmail.com

+91-11-46541400

Visit Website

FOPE was started with an objective to take up the common issues affecting the pharma industry at the national level.

investment opportunities

  • Roll out of Ayushman Bharat programme has opened up new opportunities.
  • Pharmaceuticals, nutraceuticals and biotechnology manufacturing capacity.
  • Research and development of medicament formulations for global clients.
  • Alliances with generic companies for development of drug molecules.

key investors

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments

ENABLING ENVIRONMENT

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments

News

Events